Refine by
Myocardial Injury Suppliers & Manufacturers
11 companies found
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Colchicine, an orally active alkaloid, is a potent tubulin inhibitor and a microtubule disrupting agent. Colchicine inhibits microtubule polymerization with an IC50 of 3 nM. Colchicine is also a competitive antagonist of the α3 glycine receptors ...
based inSan Francisco, CALIFORNIA (USA)
ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies for treating heart failure (HF) involving ...
ViCardia is entering Phase 2 with GP531, a potent, long-lasting, infusion therapy that treats mitochondrial dysfunction that leads to chronic heart failure and ultimately to acute decompensated heart failure. ...
based inPlanegg, GERMANY
We are a biotech company that independently develops innovative drugs and diagnostics for personalised treatment of cardiovascular diseases. We have a unique product pipeline that we are consistently moving into clinical trials. Our lead compound ...
This is the name of our therapeutic agent for the prevention of stroke and heart attack. Its principle effectiveness has already been proven in patients. It is a soluble protein which, when blood vessels are damaged, covers the damaged areas. ...
based inLuhe District, CHINA
Getein Biotech Inc. (stock code: 603387), established in 2002 and headquartered in Nanjing, is a fully integrated in vitro diagnostic (IVD) company that researches, manufactures, markets and distributes analytical medical devices and a broad range ...
Getein Cardiac Troponin l Fast Test Kit (Colloidal Gold) is intended for in vitro qualitative and semi-quantitative determination of cardiac Troponin l (cTnl) in serum, plasma or whole ...
based inYongin, SOUTH KOREA
Bilix is established based on the world’s first PEGylated bilirubin platform technology to produce numerous “First in Class” in anti-inflammatory and “Best in Class” in cancer therapy drugs in addition to achieving other business platform such as ...
Many inflammatory diseases are associated with reactive oxygen species(ROS) in the body. The bilirubin nanoparticle has strong antioxidant, ROS scavenging, and immune modulating properties which effectively eliminate the disease-causing ...
based inWellesley Hills, MASSACHUSETTS (USA)
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 50 countries, TargetMol has evolved into one of ...
based inGraz, AUSTRIA
With our innovative solutions for non-invasive continuous hemodynamic measurement, we improve patient safety, support educated diagnostic decision making and enable early prevention to help our patients grow older in good health. Our mission is to ...
Non-invasive monitoring of blood pressure and advanced hemodynamics for medium and low risk surgery. Continuous non-invasive blood pressure, cardiac output and fluid management for moderate and low-risk surgery. CNAP® Monitor provides advanced ...
based inSpringdale, ARKANSAS (USA)
NOWDiagnostics Inc., is a leader in innovative diagnostics testing. Dr. Qinwei Shi helped revolutionize lateral flow assay testing using very small sample sizes. Dr. Shi developed and perfected the platform which now is the foundation for all our ...
The ADEXUSDx Troponin I/Myoglobin (TnI/Myo) Test is an immunochromatographic assay used for the qualitative detection of human cardiac Troponin I and Myoglobin above established cut-offs in human whole blood, plasma, or serum ...
based inSan Jose, CALIFORNIA (USA)
UCP Biosciences, Inc. is a local headquarter of Chinese Peptide Group of Companies (CPC Group) located in the Silicon Valley, California, USA. It distributes Point-of-Care Drug Testing (POCT) devices, which are manufactured by its parent ...
Cardiac troponin I(cTnI), a 24kDa subunit of the troponin complex composed of 209 amino acids, regulates actin and myosin interactions by regulating the activity of Ca2+ on rhabdomyosin atpase.After myocardial ...
based inTotowa, NEW JERSEY (USA)
VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack ...
The Universal SmartECG turns an off-the-shelf computer into a full-functioning ECG machine. Connect the Universal SmartECG to a Personal Computer, laptop or tablet to acquire, store and analyze up to 12-channels of high-resolution ECG data. Perform ...
based inÜmraniye, TURKEY
Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world. Vitrosens Biotechnology headquartered in Turkey, by a group of entrepreneurs with a ...
Cardiac Troponin I (cTnI) Rapid Test Kit is designed for in vitro quantitative detection of the concentration of Cardiac Troponin I (cTnI) in human serum, plasma, and whole blood samples. It is a device that provides automated and objective ...